SPCC1322.10 Antibody

What is SPCC1322.10 and what organism is it derived from?

SPCC1322.10 refers to a gene product from Schizosaccharomyces pombe (fission yeast), as indicated by the "SPCC" prefix in its systematic name, which is common in S. pombe genome nomenclature. The antibody against this protein (catalog number CSB-PA527226XA01SXV) is manufactured by CUSABIO .

What are the typical research applications for SPCC1322.10 Antibody?

While specific validation data for this particular antibody is limited in the available literature, comparable polyclonal antibodies are typically validated for multiple applications including Western blotting, ELISA, flow cytometry, and immunohistochemistry. When establishing a new experimental protocol, researchers should conduct preliminary validation tests for their specific application .

How should I determine optimal antibody concentration for my experiments?

Determine optimal working concentration through titration experiments. For each application type, prepare a dilution series (typically 1:100 to 1:10,000) and identify the concentration that provides maximum specific signal with minimal background. The table below provides starting dilution recommendations:

How should I design controls when using SPCC1322.10 Antibody?

Effective experimental design requires multiple control types:

• Positive control: Include samples known to express the target protein (S. pombe extracts)

• Negative control: Use samples from deletion strains or non-expressing tissues

• Technical controls: Include secondary-antibody-only samples to assess non-specific binding

• Isotype control: Use non-specific antibody of the same isotype to evaluate background

• Peptide competition: Pre-incubate antibody with immunizing peptide to confirm specificity

The use of proper controls is critical for distinguishing specific from non-specific signals and ensuring experimental validity, similar to control practices employed in studies of other research antibodies .

What factors should I consider when choosing between monoclonal and polyclonal antibodies for S. pombe protein detection?

This decision depends on your experimental goals:

For novel targets like SPCC1322.10, polyclonal antibodies often provide better initial detection, while monoclonals offer greater consistency for established targets .

What protein extraction method is optimal for detecting SPCC1322.10 in S. pombe?

For effective extraction of S. pombe proteins:

• Harvest 10⁷-10⁸ cells in mid-log phase

• Wash with cold water

• Lyse using either:

  • Mechanical disruption (glass beads in lysis buffer)

  • Enzymatic treatment (zymolyase followed by detergent lysis)

• Include protease inhibitors to prevent degradation

• Clarify lysate by centrifugation (13,000g, 15 minutes)

The choice of buffer depends on subcellular localization and protein characteristics. For membrane-associated proteins, consider detergent-based extraction with NP-40 or Triton X-100.

How can I optimize Western blot protocols specifically for SPCC1322.10 detection?

Western blot optimization requires systematic adjustment of multiple parameters:

• Sample preparation:

  • Test both native and denaturing conditions

  • Include reducing agents if disulfide bonds might affect epitope accessibility

• Blocking optimization:

  • Compare BSA vs. non-fat milk (5%)

  • Test commercial blocking buffers that reduce background

• Antibody incubation:

  • Test both short (2h room temperature) and long (overnight 4°C) incubations

  • Compare different antibody dilutions

• Detection system:

  • For low abundance proteins, consider enhanced chemiluminescence

  • For quantitative analysis, fluorescent secondary antibodies provide better linearity

Document all optimization steps systematically to establish a reproducible protocol.

How might SPCC1322.10 Antibody be used in co-immunoprecipitation experiments to identify interaction partners?

Co-immunoprecipitation (Co-IP) with SPCC1322.10 Antibody requires:

• Gentle lysis conditions to preserve protein-protein interactions

  • Use buffers with mild detergents (0.1% NP-40)

  • Include protease and phosphatase inhibitors

• Antibody coupling options:

  • Direct coupling to magnetic or agarose beads

  • Use of Protein A/G beads

• Optimization parameters:

  • Antibody concentration

  • Incubation time (typically 2h to overnight)

  • Wash stringency (balance between specificity and maintaining interactions)

• Controls:

  • IgG control precipitation

  • Input control

  • Reciprocal Co-IP with antibodies against suspected interaction partners

Mass spectrometry analysis of co-precipitated proteins can identify novel interaction partners.

What are the considerations for using SPCC1322.10 Antibody in chromatin immunoprecipitation (ChIP) experiments?

If SPCC1322.10 is suspected to interact with chromatin, ChIP could reveal DNA binding sites:

• Crosslinking optimization:

  • Test formaldehyde concentrations (1-3%)

  • Optimize crosslinking time (5-20 minutes)

• Chromatin fragmentation:

  • Sonication parameters must be optimized for S. pombe

  • Target fragment size: 200-500bp

• IP conditions:

  • Higher salt concentrations than standard IP

  • Longer wash steps to reduce background

• Analysis methods:

  • qPCR for suspected binding sites

  • ChIP-seq for genome-wide binding profile

Protein-DNA interactions identified through ChIP should be validated with orthogonal methods like EMSA or reporter assays.

How can I address non-specific binding issues with SPCC1322.10 Antibody?

When encountering high background or non-specific signals:

• Increase blocking stringency:

  • Extend blocking time (1-2 hours)

  • Add 0.1-0.5% Tween-20 to blocking buffer

• Adjust antibody conditions:

  • Further dilute primary antibody

  • Add 1-5% blocking agent to antibody dilution buffer

• Modify wash protocols:

  • Increase number of washes (5-6 times)

  • Extend wash duration (10-15 minutes each)

  • Add up to 0.5M NaCl to wash buffer for increased stringency

• Pre-absorption:

  • Incubate antibody with proteins from non-expressing tissue

  • Use acetone powder from non-expressing tissue

This structured approach to troubleshooting is consistent with methodologies applied to other research antibodies .

What strategies can I employ to validate SPCC1322.10 Antibody specificity in S. pombe?

Comprehensive validation should include:

• Genetic approaches:

  • Test antibody against deletion mutant (negative control)

  • Compare signal with overexpression strain (positive control)

• Biochemical methods:

  • Peptide competition assay

  • Immunoprecipitation followed by mass spectrometry

• Orthogonal techniques:

  • Compare antibody results with tagged protein detection

  • Correlate with mRNA expression data

• Cross-reactivity assessment:

  • Test against related proteins

  • Evaluate in multiple species if applicable

Validation approaches using multiple methodologies strengthen confidence in antibody specificity, similar to validation practices used with combinatorial antibody therapies .

How should I quantify Western blot data using SPCC1322.10 Antibody for accurate comparative analysis?

For rigorous quantification:

• Image acquisition:

  • Capture data within linear range of detection

  • Use appropriate exposure to avoid saturation

• Normalization approach:

  • Use multiple housekeeping proteins as loading controls

  • Consider total protein normalization (Ponceau S or Stain-Free gels)

• Software analysis:

  • Use dedicated analysis software (ImageJ, Image Lab)

  • Define consistent measurement parameters

• Statistical considerations:

  • Perform at least three biological replicates

  • Apply appropriate statistical tests (t-test, ANOVA)

  • Report both p-values and effect sizes

A methodical approach to quantification reduces variability and increases confidence in comparative results.

How do I interpret discrepancies between SPCC1322.10 Antibody results and other detection methods?

When facing contradictory results:

• Evaluate methodological differences:

  • Antibody may detect post-translational modifications missed by other methods

  • Different detection thresholds between methods

• Consider biological variables:

  • Protein half-life vs. mRNA stability

  • Subcellular compartmentalization affecting extraction

  • Developmental or condition-specific regulation

• Technical considerations:

  • Epitope masking in certain conformations

  • Cross-reactivity with related proteins

  • Antibody lot-to-lot variation